Puma Biotechnology

US · PBYI #3745 by market cap

9.60 -0.22 -2.19%

Live - 5344 symbols - heartbeat 287s ago · 2026-10-08 09:58

Pre-market 9.68 -1.33%

After-hours 9.81 0.00%

Market cap: 495.29M
P/E (TTM): 18.81
P/B: 3.57
EPS: 0.61
Div yield: 0.00%
52W pos: 91%

Reader sentiment Are you bullish or bearish on PBYI?

Anonymous reader poll. Unscientific, not investment advice.

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Founded: 2010
CEO: Mr. Alan H. Auerbach
Employees: 179
Headquarters: Los Angeles, California, United States of America
Fiscal year end: 12-31
Website: pumabiotechnology.com

Company profile

Exchange: US
Symbol: PBYI
Market-cap rank: #3745
Market cap: 495.29M
Float cap: 380.36M
Shares out: 51.62M
Float shares: 39.64M

Sectors & themes

Biotechnology

Browse all sectors & themes

Quote time 2026-10-08 09:58:52 · For reference only, not investment advice and not tailored to your situation.